These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7299656)

  • 1. Human blood preservation: effect on in vitro protein binding.
    Jackson AJ; Miller AK; Narang PK
    J Pharm Sci; 1981 Oct; 70(10):1168-9. PubMed ID: 7299656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of age and sex on the plasma binding of acidic and basic drugs.
    Verbeeck RK; Cardinal JA; Wallace SM
    Eur J Clin Pharmacol; 1984; 27(1):91-7. PubMed ID: 6489431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma protein binding of salicylic acid, phenytoin, chlorpromazine, propranolol and pethidine using equilibrium dialysis and ultracentrifugation.
    Verbeeck RK; Cardinal JA
    Arzneimittelforschung; 1985; 35(6):903-6. PubMed ID: 4026915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral and intravenous bretylium disposition.
    Anderson JL; Patterson E; Wagner JG; Stewart JR; Behm HL; Lucchesi BR
    Clin Pharmacol Ther; 1980 Oct; 28(4):468-78. PubMed ID: 7408407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding interaction between phenytoin and valproic acid in vitro.
    Monks A; Boobis S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1978 Dec; 6(6):487-92. PubMed ID: 365209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vivo and in vitro studies of phenytoin protein binding and in vitro lipolysis in plasma of pregnant and nonpregnant rats.
    Chou RC; Levy G
    J Pharm Sci; 1984 Aug; 73(8):1121-4. PubMed ID: 6491916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein binding of phenytoin in 100 epileptic patients.
    Peterson GM; McLean S; Aldous S; Von Witt RJ; Millingen KS
    Br J Clin Pharmacol; 1982 Aug; 14(2):298-300. PubMed ID: 7104186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
    Odar-Cederlof I
    Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of heparin or salicylate infusion on serum protein binding and on concentrations of phenytoin in serum, brain and cerebrospinal fluid of rats.
    Chou RC; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):42-8. PubMed ID: 7288614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased plasma protein binding of phenytoin in patients on valproic acid.
    Dahlqvist R; Borgå O; Rane A; Walsh Z; Sjöqvist F
    Br J Clin Pharmacol; 1979 Dec; 8(6):547-52. PubMed ID: 391256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: effect of salicylic acid, temperature and total drug concentration.
    Ehrnebo M; Odar-Cederlöf I
    Eur J Clin Pharmacol; 1977; 11(1):37-42. PubMed ID: 832656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of haematocrit, plasma protein concentration and temperature of drug-containing blood in-vitro on the concentrations of the drug in the plasma.
    Tamura A; Sugimoto K; Sato T; Fujii T
    J Pharm Pharmacol; 1990 Aug; 42(8):577-80. PubMed ID: 1981587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of peptides from uremic plasma that inhibit phenytoin binding to normal plasma proteins.
    Kinniburgh DW; Boyd ND
    Clin Pharmacol Ther; 1981 Aug; 30(2):276-80. PubMed ID: 7249510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives.
    Perentesis GP; Piltz GW; Kirshcenbaum HL; Navalakha P; Aronoff W; Cutie AJ
    Am J Hosp Pharm; 1983 Jun; 40(6):1010-2. PubMed ID: 6869385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma protein binding of bupivacaine and its interaction with other drugs in man.
    Ghoneim MM; Pandya H
    Br J Anaesth; 1974 Jun; 46(6):435-8. PubMed ID: 4458761
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma protein binding of phenytoin after cholecystectomy and neurosurgical operations.
    Elfström J
    Acta Neurol Scand; 1977 Jun; 55(6):455-64. PubMed ID: 878836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The use of expired lyophylized plasma for the preparation of protein albumin solutions to be used as "plasma expanders". Preliminary technical].
    Terzi I; Piazzi E
    Ann Med Nav (Roma); 1968; 73(5):395-406. PubMed ID: 5743215
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma protein binding of drugs as a function of age in adult human subjects.
    Bender AD; Post A; Meier JP; Higson JE; Reichard G
    J Pharm Sci; 1975 Oct; 64(10):1711-3. PubMed ID: 1185544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.